Hernando Yesid Estupiñan Velasquez (H Yesid Estupiñán, L E Ballesteros-Acuña)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Folia morphologica

This page only lists publications with an associated author ORCID identifier.

Publications

Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Hernando Yesid Estupiñan Velasquez, Thibault Bouderlique, Chenfei He, Anna Berglöf, Andrea Cappelleri, Nicolai Sebastian Frengen, Rula Zain, Mikael C I Karlsson, Robert Månsson, Carl Inge Edvard Smith
In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood advances 8 (8) (2024)
Hernando Yesid Estupiñan Velasquez, Fabián Gómez-Torres, F A Gómez-Torres
Morphologic characterization of the posterior inferior cerebellar artery. A direct anatomic study. Folia morphologica (2021)
Hernando Yesid Estupiñan Velasquez, Qing Wang, Anna Berglöf, Gerard C P Schaafsma, Yuye Shi, Litao Zhou, Dara K Mohammad, Liang Yu, Mauno Vihinen, Rula Zain, Carl Inge Edvard Smith
BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib. Leukemia 35 (5) (2021)